UG Healthcare Corp. Ltd. (8K7) AI Stock Analysis

• Market Cap: S$60.51M
• Dividend Yield: N/A
• Average Volume (3M): 94.64K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.75
• Revenue Growth: 25.06%
• EPS Growth: 37.11%
• Country: SG
• Employees: 898
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Instruments & Supplies
• EPS (TTM): >-0.01
• Shares Outstanding: 623,825,800
• 10 Day Avg. Volume: 10,850
• 30 Day Avg. Volume: 94,640
• PEG Ratio: 0.48
• Price to Book (P/B): 0.43
• Price to Sales (P/S): 0.47
• P/FCF Ratio: -8.39
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: S$0.10 ▼(-4.00% Downside)

The overall stock score is primarily influenced by financial performance challenges, including profitability and cash flow issues, despite strong revenue growth. Technical indicators suggest a neutral to slightly bearish trend, while valuation concerns arise from negative earnings and lack of dividend yield.

Positive Factors

Revenue Growth

Strong revenue growth indicates robust demand for UG Healthcare's products, enhancing its market position and potential for future expansion.

Diversified Revenue Model

A diversified revenue model reduces dependency on single income streams, providing stability and resilience against market fluctuations.

Moderate Debt Level

Moderate leverage provides financial stability, allowing UG Healthcare to invest in growth opportunities without excessive risk.

Negative Factors

Profitability Challenges

Negative profit margins suggest inefficiencies or high costs, which could impede long-term financial health if not addressed.

Cash Flow Issues

Declining cash flow generation limits the company's ability to fund operations and invest in growth, posing a risk to sustainability.

Negative Return on Equity

Negative ROE indicates that the company is not generating sufficient returns on shareholder investments, impacting investor confidence.

UG Healthcare Corp. Ltd. Business Overview & Revenue Model

Company Description

UG Healthcare Corp. Ltd. (8K7) is a prominent player in the healthcare sector, primarily focused on the manufacturing and distribution of medical gloves and other healthcare-related products. The company operates in various markets, providing essential products to hospitals, clinics, and healthcare providers worldwide. With a commitment to quality and innovation, UG Healthcare has established a strong reputation for its nitrile and latex gloves, catering to both the medical and industrial sectors.

How the Company Makes Money

UG Healthcare Corp. Ltd. generates revenue through the sale of its core products, primarily medical gloves, which are sold to healthcare facilities, distributors, and retailers globally. The company benefits from a diversified revenue model that includes both direct sales and partnerships with key distributors in various regions. Additionally, UG Healthcare leverages economies of scale in its manufacturing processes, allowing for competitive pricing and increased profit margins. The company's focus on quality assurance and compliance with international standards further enhances its market position, attracting long-term contracts and repeat business from clients. Significant partnerships with healthcare institutions and suppliers also contribute to its earnings, providing a steady stream of revenue.

UG Healthcare Corp. Ltd. Financial Statement Overview

Summary

UG Healthcare Corp. Ltd. shows strong revenue growth but faces profitability and cash flow challenges. The company has a moderate debt level, providing some financial stability, but negative returns on equity and cash flow issues are concerning.

Income Statement

UG Healthcare Corp. Ltd. has experienced significant revenue growth of 51.77% in the latest year, indicating strong sales performance. However, the company is facing profitability challenges, with a negative net profit margin of -2.63% and an EBIT margin of -0.87%. This suggests that despite increasing revenues, the company is struggling to convert sales into profits, potentially due to high operating costs or other inefficiencies.

Balance Sheet

The company's debt-to-equity ratio of 0.30 indicates a moderate level of leverage, which is relatively stable compared to previous years. However, the return on equity is negative at -2.39%, reflecting the company's inability to generate positive returns for shareholders. The equity ratio stands at 68.33%, suggesting a strong equity base relative to total assets, which provides some financial stability.

Cash Flow

UG Healthcare Corp. Ltd. has a negative free cash flow growth rate of -78.07%, indicating a significant decline in cash generation. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. However, the free cash flow to net income ratio of 1.70 suggests that the company is generating more free cash flow relative to its net income, which could be a positive sign if sustained.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	94.93M	144.07M	115.20M	101.13M	232.60M	338.40M
Gross Profit	3.43M	34.74M	25.87M	1.45M	84.39M	196.16M
EBITDA	-21.20M	2.47M	-3.94M	-23.97M	53.37M	163.04M
Net Income	-20.93M	-3.79M	-6.06M	-20.73M	36.80M	118.77M
Balance Sheet
Total Assets	215.39M	232.35M	226.45M	230.00M	288.04M	268.29M
Cash, Cash Equivalents and Short-Term Investments	45.13M	23.29M	28.00M	61.74M	100.22M	68.44M
Total Debt	28.46M	47.36M	43.72M	31.13M	17.98M	16.74M
Total Liabilities	44.08M	76.03M	65.17M	48.81M	52.98M	73.53M
Stockholders Equity	171.94M	158.73M	163.39M	180.84M	228.90M	190.64M
Cash Flow
Free Cash Flow	-36.98M	-8.11M	-20.71M	-47.17M	31.63M	61.47M
Operating Cash Flow	-34.35M	-4.78M	-18.16M	-39.14M	53.95M	81.16M
Investing Cash Flow	-2.63M	-3.21M	-22.73M	-8.03M	-21.19M	-18.89M
Financing Cash Flow	4.62M	3.24M	8.36M	8.70M	-973.00K	-3.14M

UG Healthcare Corp. Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:8K7, the sentiment is Negative. The current price of 0.1 is below the 20-day moving average (MA) of 0.10, below the 50-day MA of 0.10, and below the 200-day MA of 0.11, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.34 is Neutral, neither overbought nor oversold. The STOCH value of 200.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:8K7.

UG Healthcare Corp. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AP4	73 Outperform	S$1.27B	18.67	14.10%	8.80%	4.74%	-17.18%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
8K7	48 Neutral	S$60.51M	-15.90	-2.33%	―	25.06%	37.11%

UG Healthcare Corp. Ltd. Corporate Events

UG Healthcare Corp. Ltd. Conducts Annual General Meeting

UG Healthcare Corp. Ltd. held its Annual General Meeting on October 29, 2025, at YMCA @ One Orchard, Singapore. The meeting was chaired by Mr. Wong Fook Choy Sunny, with Mr. Lee Jun Yih, Joint CEO, presenting the company’s business and financial performance for the fiscal year ending June 30, 2025. Shareholders were given the opportunity to ask questions in person, and all resolutions were voted on by poll as per company regulations.